Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Differential utilization and localization of ErbB receptor tyrosine kinases in skin compared to normal and malignant keratinocytes.

Stoll SW, Kansra S, Peshick S, Fry DW, Leopold WR, Wiesen JF, Sibilia M, Zhang T, Werb Z, Derynck R, Wagner EF, Elder JT.

Neoplasia. 2001 Jul-Aug;3(4):339-50.

PMID:
11571634
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The relative role of ErbB1-4 receptor tyrosine kinases in radiation signal transduction responses of human carcinoma cells.

Bowers G, Reardon D, Hewitt T, Dent P, Mikkelsen RB, Valerie K, Lammering G, Amir C, Schmidt-Ullrich RK.

Oncogene. 2001 Mar 15;20(11):1388-97. Review. Erratum in: Oncogene 2001 Jun 28;20(29):3927.

PMID:
11313882
[PubMed - indexed for MEDLINE]
Free Article
3.

The neuregulin-I/ErbB signaling system in development and disease.

Britsch S.

Adv Anat Embryol Cell Biol. 2007;190:1-65. Review.

PMID:
17432114
[PubMed - indexed for MEDLINE]
4.

ERBB3/HER3 and ERBB2/HER2 duet in mammary development and breast cancer.

Stern DF.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):215-23. doi: 10.1007/s10911-008-9083-7. Epub 2008 May 3. Review.

PMID:
18454306
[PubMed - indexed for MEDLINE]
5.

CI-1033, a pan-erbB tyrosine kinase inhibitor.

Slichenmyer WJ, Elliott WL, Fry DW.

Semin Oncol. 2001 Oct;28(5 Suppl 16):80-5. Review.

PMID:
11706399
[PubMed - indexed for MEDLINE]
6.

ErbB receptors and epithelial-cadherin-catenin complex in human carcinomas.

Yasmeen A, Bismar TA, Al Moustafa AE.

Future Oncol. 2006 Dec;2(6):765-81. Review.

PMID:
17155902
[PubMed - indexed for MEDLINE]
7.

E3 ubiquitin ligases in ErbB receptor quantity control.

Carraway KL 3rd.

Semin Cell Dev Biol. 2010 Dec;21(9):936-43. doi: 10.1016/j.semcdb.2010.09.006. Epub 2010 Sep 22. Review.

PMID:
20868762
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk